Comparison of Ultrasound Guided Versus Blind Corticosteroid Injection for Trochanteric Bursitis

Not Applicable

Completed

• Conditions: Bursitis
• Interventions: Procedure: Trochanter bursa injections; Device: Ultrasound

• Registration Number: NCT02221817
• Lead Sponsor: West Virginia University

Brief Summary

Trochanteric bursitis is a common condition, effecting 20% of the population. \\Most with trochanteric bursitis experience chronic intermittent or continuous hip pain at and around the greater trochanter.

The cause of trochanteric bursitis is believed to be a result of inflammation of the bursa, though this has not been confirmed. Accordingly, the use of corticosteroid injections has been shown to provide considerable relief. However, routine "blind" injections, those performed without the aid of imaging, such as fluoroscopy, have shown limited success in the appropriate needle placement. Fortunately, blind injections have yielded positive results in majority of the cases. Additionally, the use of fluoroscopy has not shown to improve clinical outcome for trochanter bursa injections.

Although the use of fluoroscopy has not shown positive benefit, other modes of imaging, such as ultrasound have not been studied and may be more useful. Fluoroscopy allows for bony-landmark based injections. Ultrasound allows for direct visualization of the soft tissue structures such as the bursa and has gained significant support for use in musculoskeletal injections. This prospective blinded study's aim is to evaluate, if any, the benefit of an ultrasound guided injection and whether ultrasound should be routinely used during trochanter bursa injections.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-08
• Study First Submitted: 2014-08-16
• Study First Submitted QC: 2014-08-18
• Study First Posted: 2014-08-20
• Primary Completion: 2015-04
• Study Completion: 2015-04
• Results First Submitted: 2020-12-22
• Results First Submitted QC: 2020-12-22
• Results First Posted: 2021-01-20
• Status Verified: 2021-09
• Last Update Submitted: 2021-09-23
• Last Update Posted: 2021-10-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1. Clinical diagnosis of trochanteric bursitis
2. 18 years of age or older when written informed consent is obtained
3. Signed Institutional Review Board (IRB) approved informed consent form

Exclusion Criteria

1. Allergy to triamcinolone or bupivicaine
2. Coagulopathy
3. Active Infection
4. Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or complete study assessments

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Ultrasound	Trochanter bursa injections	Trochanter injection
Ultrasound	Ultrasound	Trochanter injection
Blind	Trochanter bursa injections	Trochanter injection

Primary Outcome Measures

Name	Time	Method
Pain Intensity Measured on Visual Analog Scale (VAS)	3 month

Secondary Outcome Measures

Name	Time	Method
Adverse Effects	2 weeks, 3 month
Disability Measured on Becks Disability Scale	Baseline, 2 weeks, 3 month
Pain Improvement	2 weeks, 3 months	Percent improvement

Trial Locations

Locations (1)

West Virginia University Hospitals; 🇺🇸 Morgantown, West Virginia, United States